AbbVie Inc. (ABBV)

NYSE · Healthcare · Drug Manufacturers - General
$286.20+0.94%As of 2026-11-22 · USD
Last session low $284.85Last session high $290.23
52-week low $190.7552-week high $302.93
Market cap
$505.89B
Sector
Healthcare
P/E (TTM)
49.2x
Dividend yield
2.42%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)52.4In the neutral range (30 to 70)
MACD (12, 26, 9)2.69Below its signal line (4.27); histogram -1.57
Bollinger %B (20, 2)21%Inside the bands (283.00 to 298.15)
SMA 20290.57Price is 1.5% below
SMA 50279.06Price is 2.6% above
SMA 200242.45Price is 18.0% above
ATR (20)2.32% of priceAverage true range per day
52-week position85%In the upper part of the 190.75 to 302.93 range

About AbbVie Inc.

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.

Latest fiscal yearEnded 2025-12-31: revenue of $61.16B and an operating margin of 32.8%.

More in Drug Manufacturers - General